Global Cardiac Biomarker POCT Diagnostic Device Supply, Demand and Key Producers, 2026-2032
The global Cardiac Biomarker POCT Diagnostic Device market size is expected to reach $ 382 million by 2032, rising at a market growth of 6.2% CAGR during the forecast period (2026-2032).
The Cardiac Biomarker POCT Diagnostic Device is designed for emergency departments, chest pain centers, intensive care units, cardiology outpatient clinics, primary care, and pre-hospital emergency use. It utilizes fluorescence immunoassay, chemiluminescence, and microfluidic technologies to measure cardiac injury markers including cTnI, hs-cTnI, cTnT, CK-MB, and myoglobin, as well as heart failure biomarkers BNP and NT-proBNP. Upstream materials include highly specific monoclonal antibodies, fluorescent labels, microfluidic chips, and dedicated consumables. The main customers are hospitals, emergency and chest pain centers, ICUs, cardiology clinics, primary care facilities, and pre-hospital emergency services worldwide. In 2025, global production capacity is approximately 26,500 units, with actual sales around 21,380 units, an average ex-factory price of 11,200 USD per unit, and a gross margin range of 38%?50%.
The global market for cardiac biomarker POCT diagnostic devices exhibits a multi-layered competitive structure, with high-end companies in North America, Europe, and Japan coexisting with mid-tier manufacturers in China and South Korea. Emergency departments, chest pain centers, and ICUs remain core application areas. Platforms have evolved from single-marker testing to high-sensitivity troponin, multi-marker panels, microfluidic, and fluorescence immunoassay technologies, creating a complete ecosystem of analyzers and reagent consumables. Manufacturers establish recurring revenue and customer stickiness through consumable binding, hospital data integration, and workflow coordination. Chinese and Korean companies expand market share through cost control, rapid product iteration, and export channels, while Western and Japanese leaders maintain technological and brand advantages in high-end hospital settings, also pushing the integration of high-sensitivity assays and connected data systems.
Future trends indicate continuous growth in platform-based, multi-marker testing and high-sensitivity troponin penetration. Next-generation devices will increasingly feature microfluidic chips, dry fluorescence assays, automated operation systems, portability, and networked functionality. Information integration and data management capabilities are becoming critical for platform competitiveness, driving optimization of emergency workflows, remote monitoring, and differentiated clinical decision support. Regionally, Chinese and Korean firms are rapidly expanding mid-tier and export markets, while Western and Japanese companies maintain leadership in high-end hospitals, forming a globally multi-tiered, regionally complementary market. Clinical validation and standardization of new technologies will further enhance device reliability and physician acceptance, supporting sustained market growth.
Market growth is primarily driven by strong clinical demand for rapid and high-precision testing. High-sensitivity assays and multi-marker panels optimize acute myocardial infarction triage, heart failure evaluation, and critical patient monitoring. Technological iteration and new product development not only enhance platform capabilities but also provide opportunities for market share expansion and improved gross margins. Downstream customers include hospitals, emergency and chest pain centers, ICUs, cardiology outpatient clinics, primary care facilities, and pre-hospital emergency services. Companies achieve sustainable revenue through device-consumable integration, client management, and service upgrades, establishing long-term competitive barriers in clinical protocols and hospital workflows.
Obstacles include stringent regulatory and clinical validation requirements, hospital procurement pacing, and constraints from reimbursement and payment systems. Low-sensitivity or single-marker platforms may be displaced by high-sensitivity, multi-marker, automated, and connected platforms. Regional differences in policy, regulation, and clinical adoption may also influence market growth. A company's R&D capabilities, clinical support system, marketing strategies, and service network directly determine its competitive position. Technological innovation and comprehensive service systems remain critical to overcoming market barriers and driving sustainable industry development.
This report studies the global Cardiac Biomarker POCT Diagnostic Device production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cardiac Biomarker POCT Diagnostic Device and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiac Biomarker POCT Diagnostic Device that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cardiac Biomarker POCT Diagnostic Device total production and demand, 2021-2032, (Units)
Global Cardiac Biomarker POCT Diagnostic Device total production value, 2021-2032, (USD Million)
Global Cardiac Biomarker POCT Diagnostic Device production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Cardiac Biomarker POCT Diagnostic Device consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Cardiac Biomarker POCT Diagnostic Device domestic production, consumption, key domestic manufacturers and share
Global Cardiac Biomarker POCT Diagnostic Device production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Cardiac Biomarker POCT Diagnostic Device production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Cardiac Biomarker POCT Diagnostic Device production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Cardiac Biomarker POCT Diagnostic Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott Laboratories, QuidelOrtho Corporation, Radiometer Medical, Siemens Healthineers, PHC Holdings, Guangzhou Wondfo Biotech, Getein Biotech, Boditech Med, SD BIOSENSOR, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cardiac Biomarker POCT Diagnostic Device market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cardiac Biomarker POCT Diagnostic Device Market, By Region:
1. How big is the global Cardiac Biomarker POCT Diagnostic Device market?
2. What is the demand of the global Cardiac Biomarker POCT Diagnostic Device market?
3. What is the year over year growth of the global Cardiac Biomarker POCT Diagnostic Device market?
4. What is the production and production value of the global Cardiac Biomarker POCT Diagnostic Device market?
5. Who are the key producers in the global Cardiac Biomarker POCT Diagnostic Device market?
6. What are the growth factors driving the market demand?
The Cardiac Biomarker POCT Diagnostic Device is designed for emergency departments, chest pain centers, intensive care units, cardiology outpatient clinics, primary care, and pre-hospital emergency use. It utilizes fluorescence immunoassay, chemiluminescence, and microfluidic technologies to measure cardiac injury markers including cTnI, hs-cTnI, cTnT, CK-MB, and myoglobin, as well as heart failure biomarkers BNP and NT-proBNP. Upstream materials include highly specific monoclonal antibodies, fluorescent labels, microfluidic chips, and dedicated consumables. The main customers are hospitals, emergency and chest pain centers, ICUs, cardiology clinics, primary care facilities, and pre-hospital emergency services worldwide. In 2025, global production capacity is approximately 26,500 units, with actual sales around 21,380 units, an average ex-factory price of 11,200 USD per unit, and a gross margin range of 38%?50%.
The global market for cardiac biomarker POCT diagnostic devices exhibits a multi-layered competitive structure, with high-end companies in North America, Europe, and Japan coexisting with mid-tier manufacturers in China and South Korea. Emergency departments, chest pain centers, and ICUs remain core application areas. Platforms have evolved from single-marker testing to high-sensitivity troponin, multi-marker panels, microfluidic, and fluorescence immunoassay technologies, creating a complete ecosystem of analyzers and reagent consumables. Manufacturers establish recurring revenue and customer stickiness through consumable binding, hospital data integration, and workflow coordination. Chinese and Korean companies expand market share through cost control, rapid product iteration, and export channels, while Western and Japanese leaders maintain technological and brand advantages in high-end hospital settings, also pushing the integration of high-sensitivity assays and connected data systems.
Future trends indicate continuous growth in platform-based, multi-marker testing and high-sensitivity troponin penetration. Next-generation devices will increasingly feature microfluidic chips, dry fluorescence assays, automated operation systems, portability, and networked functionality. Information integration and data management capabilities are becoming critical for platform competitiveness, driving optimization of emergency workflows, remote monitoring, and differentiated clinical decision support. Regionally, Chinese and Korean firms are rapidly expanding mid-tier and export markets, while Western and Japanese companies maintain leadership in high-end hospitals, forming a globally multi-tiered, regionally complementary market. Clinical validation and standardization of new technologies will further enhance device reliability and physician acceptance, supporting sustained market growth.
Market growth is primarily driven by strong clinical demand for rapid and high-precision testing. High-sensitivity assays and multi-marker panels optimize acute myocardial infarction triage, heart failure evaluation, and critical patient monitoring. Technological iteration and new product development not only enhance platform capabilities but also provide opportunities for market share expansion and improved gross margins. Downstream customers include hospitals, emergency and chest pain centers, ICUs, cardiology outpatient clinics, primary care facilities, and pre-hospital emergency services. Companies achieve sustainable revenue through device-consumable integration, client management, and service upgrades, establishing long-term competitive barriers in clinical protocols and hospital workflows.
Obstacles include stringent regulatory and clinical validation requirements, hospital procurement pacing, and constraints from reimbursement and payment systems. Low-sensitivity or single-marker platforms may be displaced by high-sensitivity, multi-marker, automated, and connected platforms. Regional differences in policy, regulation, and clinical adoption may also influence market growth. A company's R&D capabilities, clinical support system, marketing strategies, and service network directly determine its competitive position. Technological innovation and comprehensive service systems remain critical to overcoming market barriers and driving sustainable industry development.
This report studies the global Cardiac Biomarker POCT Diagnostic Device production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cardiac Biomarker POCT Diagnostic Device and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiac Biomarker POCT Diagnostic Device that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cardiac Biomarker POCT Diagnostic Device total production and demand, 2021-2032, (Units)
Global Cardiac Biomarker POCT Diagnostic Device total production value, 2021-2032, (USD Million)
Global Cardiac Biomarker POCT Diagnostic Device production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Cardiac Biomarker POCT Diagnostic Device consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Cardiac Biomarker POCT Diagnostic Device domestic production, consumption, key domestic manufacturers and share
Global Cardiac Biomarker POCT Diagnostic Device production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Cardiac Biomarker POCT Diagnostic Device production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Cardiac Biomarker POCT Diagnostic Device production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Cardiac Biomarker POCT Diagnostic Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott Laboratories, QuidelOrtho Corporation, Radiometer Medical, Siemens Healthineers, PHC Holdings, Guangzhou Wondfo Biotech, Getein Biotech, Boditech Med, SD BIOSENSOR, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cardiac Biomarker POCT Diagnostic Device market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cardiac Biomarker POCT Diagnostic Device Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Fluorescence Immunoassay
- Chemiluminescence Immunoassay
- Other
- Handheld
- Benchtop
- Other
- Troponin-focused
- Natriuretic Peptide-focused
- Other
- Hospital
- Clinic
- Others
- Roche
- Abbott Laboratories
- QuidelOrtho Corporation
- Radiometer Medical
- Siemens Healthineers
- PHC Holdings
- Guangzhou Wondfo Biotech
- Getein Biotech
- Boditech Med
- SD BIOSENSOR
- Lepu Medical Technology
- Humasis
- NanoEntek
- Xiamen Biotime Biotechnology
- Nanjing Lansion Biotechnology
- Shenzhen Micropoint Biotechnologies
- Shijiazhuang Hipro Biotechnology
- AEHEALTH
- Guangzhou KOFA Biotechnology
- Response Biomedical
1. How big is the global Cardiac Biomarker POCT Diagnostic Device market?
2. What is the demand of the global Cardiac Biomarker POCT Diagnostic Device market?
3. What is the year over year growth of the global Cardiac Biomarker POCT Diagnostic Device market?
4. What is the production and production value of the global Cardiac Biomarker POCT Diagnostic Device market?
5. Who are the key producers in the global Cardiac Biomarker POCT Diagnostic Device market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cardiac Biomarker POCT Diagnostic Device Introduction
1.2 World Cardiac Biomarker POCT Diagnostic Device Supply & Forecast
1.2.1 World Cardiac Biomarker POCT Diagnostic Device Production Value (2021 & 2025 & 2032)
1.2.2 World Cardiac Biomarker POCT Diagnostic Device Production (2021-2032)
1.2.3 World Cardiac Biomarker POCT Diagnostic Device Pricing Trends (2021-2032)
1.3 World Cardiac Biomarker POCT Diagnostic Device Production by Region (Based on Production Site)
1.3.1 World Cardiac Biomarker POCT Diagnostic Device Production Value by Region (2021-2032)
1.3.2 World Cardiac Biomarker POCT Diagnostic Device Production by Region (2021-2032)
1.3.3 World Cardiac Biomarker POCT Diagnostic Device Average Price by Region (2021-2032)
1.3.4 North America Cardiac Biomarker POCT Diagnostic Device Production (2021-2032)
1.3.5 Europe Cardiac Biomarker POCT Diagnostic Device Production (2021-2032)
1.3.6 China Cardiac Biomarker POCT Diagnostic Device Production (2021-2032)
1.3.7 Japan Cardiac Biomarker POCT Diagnostic Device Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cardiac Biomarker POCT Diagnostic Device Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cardiac Biomarker POCT Diagnostic Device Major Market Trends
2 DEMAND SUMMARY
2.1 World Cardiac Biomarker POCT Diagnostic Device Demand (2021-2032)
2.2 World Cardiac Biomarker POCT Diagnostic Device Consumption by Region
2.2.1 World Cardiac Biomarker POCT Diagnostic Device Consumption by Region (2021-2026)
2.2.2 World Cardiac Biomarker POCT Diagnostic Device Consumption Forecast by Region (2027-2032)
2.3 United States Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
2.4 China Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
2.5 Europe Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
2.6 Japan Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
2.7 South Korea Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
2.8 ASEAN Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
2.9 India Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Cardiac Biomarker POCT Diagnostic Device Production Value by Manufacturer (2021-2026)
3.2 World Cardiac Biomarker POCT Diagnostic Device Production by Manufacturer (2021-2026)
3.3 World Cardiac Biomarker POCT Diagnostic Device Average Price by Manufacturer (2021-2026)
3.4 Cardiac Biomarker POCT Diagnostic Device Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cardiac Biomarker POCT Diagnostic Device Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cardiac Biomarker POCT Diagnostic Device in 2025
3.5.3 Global Concentration Ratios (CR8) for Cardiac Biomarker POCT Diagnostic Device in 2025
3.6 Cardiac Biomarker POCT Diagnostic Device Market: Overall Company Footprint Analysis
3.6.1 Cardiac Biomarker POCT Diagnostic Device Market: Region Footprint
3.6.2 Cardiac Biomarker POCT Diagnostic Device Market: Company Product Type Footprint
3.6.3 Cardiac Biomarker POCT Diagnostic Device Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Value Comparison
4.1.1 United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Comparison
4.2.1 United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Cardiac Biomarker POCT Diagnostic Device Consumption Comparison
4.3.1 United States VS China: Cardiac Biomarker POCT Diagnostic Device Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Cardiac Biomarker POCT Diagnostic Device Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Cardiac Biomarker POCT Diagnostic Device Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Cardiac Biomarker POCT Diagnostic Device Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value (2021-2026)
4.4.3 United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production (2021-2026)
4.5 China Based Cardiac Biomarker POCT Diagnostic Device Manufacturers and Market Share
4.5.1 China Based Cardiac Biomarker POCT Diagnostic Device Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value (2021-2026)
4.5.3 China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production (2021-2026)
4.6 Rest of World Based Cardiac Biomarker POCT Diagnostic Device Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Cardiac Biomarker POCT Diagnostic Device Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cardiac Biomarker POCT Diagnostic Device Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Fluorescence Immunoassay
5.2.2 Chemiluminescence Immunoassay
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Cardiac Biomarker POCT Diagnostic Device Production by Type (2021-2032)
5.3.2 World Cardiac Biomarker POCT Diagnostic Device Production Value by Type (2021-2032)
5.3.3 World Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY FORM
6.1 World Cardiac Biomarker POCT Diagnostic Device Market Size Overview by Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Form
6.2.1 Handheld
6.2.2 Benchtop
6.2.3 Other
6.3 Market Segment by Form
6.3.1 World Cardiac Biomarker POCT Diagnostic Device Production by Form (2021-2032)
6.3.2 World Cardiac Biomarker POCT Diagnostic Device Production Value by Form (2021-2032)
6.3.3 World Cardiac Biomarker POCT Diagnostic Device Average Price by Form (2021-2032)
7 MARKET ANALYSIS BY CARDIAC BIOMARKER
7.1 World Cardiac Biomarker POCT Diagnostic Device Market Size Overview by Cardiac Biomarker: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Cardiac Biomarker
7.2.1 Troponin-focused
7.2.2 Natriuretic Peptide-focused
7.2.3 Other
7.3 Market Segment by Cardiac Biomarker
7.3.1 World Cardiac Biomarker POCT Diagnostic Device Production by Cardiac Biomarker (2021-2032)
7.3.2 World Cardiac Biomarker POCT Diagnostic Device Production Value by Cardiac Biomarker (2021-2032)
7.3.3 World Cardiac Biomarker POCT Diagnostic Device Average Price by Cardiac Biomarker (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cardiac Biomarker POCT Diagnostic Device Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Cardiac Biomarker POCT Diagnostic Device Production by Application (2021-2032)
8.3.2 World Cardiac Biomarker POCT Diagnostic Device Production Value by Application (2021-2032)
8.3.3 World Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Roche
9.1.1 Roche Details
9.1.2 Roche Major Business
9.1.3 Roche Cardiac Biomarker POCT Diagnostic Device Product and Services
9.1.4 Roche Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Roche Recent Developments/Updates
9.1.6 Roche Competitive Strengths & Weaknesses
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Details
9.2.2 Abbott Laboratories Major Business
9.2.3 Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Product and Services
9.2.4 Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Abbott Laboratories Recent Developments/Updates
9.2.6 Abbott Laboratories Competitive Strengths & Weaknesses
9.3 QuidelOrtho Corporation
9.3.1 QuidelOrtho Corporation Details
9.3.2 QuidelOrtho Corporation Major Business
9.3.3 QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Product and Services
9.3.4 QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 QuidelOrtho Corporation Recent Developments/Updates
9.3.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
9.4 Radiometer Medical
9.4.1 Radiometer Medical Details
9.4.2 Radiometer Medical Major Business
9.4.3 Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Product and Services
9.4.4 Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Radiometer Medical Recent Developments/Updates
9.4.6 Radiometer Medical Competitive Strengths & Weaknesses
9.5 Siemens Healthineers
9.5.1 Siemens Healthineers Details
9.5.2 Siemens Healthineers Major Business
9.5.3 Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Product and Services
9.5.4 Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Siemens Healthineers Recent Developments/Updates
9.5.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.6 PHC Holdings
9.6.1 PHC Holdings Details
9.6.2 PHC Holdings Major Business
9.6.3 PHC Holdings Cardiac Biomarker POCT Diagnostic Device Product and Services
9.6.4 PHC Holdings Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 PHC Holdings Recent Developments/Updates
9.6.6 PHC Holdings Competitive Strengths & Weaknesses
9.7 Guangzhou Wondfo Biotech
9.7.1 Guangzhou Wondfo Biotech Details
9.7.2 Guangzhou Wondfo Biotech Major Business
9.7.3 Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
9.7.4 Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Guangzhou Wondfo Biotech Recent Developments/Updates
9.7.6 Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
9.8 Getein Biotech
9.8.1 Getein Biotech Details
9.8.2 Getein Biotech Major Business
9.8.3 Getein Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
9.8.4 Getein Biotech Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Getein Biotech Recent Developments/Updates
9.8.6 Getein Biotech Competitive Strengths & Weaknesses
9.9 Boditech Med
9.9.1 Boditech Med Details
9.9.2 Boditech Med Major Business
9.9.3 Boditech Med Cardiac Biomarker POCT Diagnostic Device Product and Services
9.9.4 Boditech Med Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Boditech Med Recent Developments/Updates
9.9.6 Boditech Med Competitive Strengths & Weaknesses
9.10 SD BIOSENSOR
9.10.1 SD BIOSENSOR Details
9.10.2 SD BIOSENSOR Major Business
9.10.3 SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Product and Services
9.10.4 SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 SD BIOSENSOR Recent Developments/Updates
9.10.6 SD BIOSENSOR Competitive Strengths & Weaknesses
9.11 Lepu Medical Technology
9.11.1 Lepu Medical Technology Details
9.11.2 Lepu Medical Technology Major Business
9.11.3 Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Product and Services
9.11.4 Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Lepu Medical Technology Recent Developments/Updates
9.11.6 Lepu Medical Technology Competitive Strengths & Weaknesses
9.12 Humasis
9.12.1 Humasis Details
9.12.2 Humasis Major Business
9.12.3 Humasis Cardiac Biomarker POCT Diagnostic Device Product and Services
9.12.4 Humasis Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Humasis Recent Developments/Updates
9.12.6 Humasis Competitive Strengths & Weaknesses
9.13 NanoEntek
9.13.1 NanoEntek Details
9.13.2 NanoEntek Major Business
9.13.3 NanoEntek Cardiac Biomarker POCT Diagnostic Device Product and Services
9.13.4 NanoEntek Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 NanoEntek Recent Developments/Updates
9.13.6 NanoEntek Competitive Strengths & Weaknesses
9.14 Xiamen Biotime Biotechnology
9.14.1 Xiamen Biotime Biotechnology Details
9.14.2 Xiamen Biotime Biotechnology Major Business
9.14.3 Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
9.14.4 Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Xiamen Biotime Biotechnology Recent Developments/Updates
9.14.6 Xiamen Biotime Biotechnology Competitive Strengths & Weaknesses
9.15 Nanjing Lansion Biotechnology
9.15.1 Nanjing Lansion Biotechnology Details
9.15.2 Nanjing Lansion Biotechnology Major Business
9.15.3 Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
9.15.4 Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Nanjing Lansion Biotechnology Recent Developments/Updates
9.15.6 Nanjing Lansion Biotechnology Competitive Strengths & Weaknesses
9.16 Shenzhen Micropoint Biotechnologies
9.16.1 Shenzhen Micropoint Biotechnologies Details
9.16.2 Shenzhen Micropoint Biotechnologies Major Business
9.16.3 Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Product and Services
9.16.4 Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Shenzhen Micropoint Biotechnologies Recent Developments/Updates
9.16.6 Shenzhen Micropoint Biotechnologies Competitive Strengths & Weaknesses
9.17 Shijiazhuang Hipro Biotechnology
9.17.1 Shijiazhuang Hipro Biotechnology Details
9.17.2 Shijiazhuang Hipro Biotechnology Major Business
9.17.3 Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
9.17.4 Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Shijiazhuang Hipro Biotechnology Recent Developments/Updates
9.17.6 Shijiazhuang Hipro Biotechnology Competitive Strengths & Weaknesses
9.18 AEHEALTH
9.18.1 AEHEALTH Details
9.18.2 AEHEALTH Major Business
9.18.3 AEHEALTH Cardiac Biomarker POCT Diagnostic Device Product and Services
9.18.4 AEHEALTH Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 AEHEALTH Recent Developments/Updates
9.18.6 AEHEALTH Competitive Strengths & Weaknesses
9.19 Guangzhou KOFA Biotechnology
9.19.1 Guangzhou KOFA Biotechnology Details
9.19.2 Guangzhou KOFA Biotechnology Major Business
9.19.3 Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
9.19.4 Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Guangzhou KOFA Biotechnology Recent Developments/Updates
9.19.6 Guangzhou KOFA Biotechnology Competitive Strengths & Weaknesses
9.20 Response Biomedical
9.20.1 Response Biomedical Details
9.20.2 Response Biomedical Major Business
9.20.3 Response Biomedical Cardiac Biomarker POCT Diagnostic Device Product and Services
9.20.4 Response Biomedical Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Response Biomedical Recent Developments/Updates
9.20.6 Response Biomedical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cardiac Biomarker POCT Diagnostic Device Industry Chain
10.2 Cardiac Biomarker POCT Diagnostic Device Upstream Analysis
10.2.1 Cardiac Biomarker POCT Diagnostic Device Core Raw Materials
10.2.2 Main Manufacturers of Cardiac Biomarker POCT Diagnostic Device Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Cardiac Biomarker POCT Diagnostic Device Production Mode
10.6 Cardiac Biomarker POCT Diagnostic Device Procurement Model
10.7 Cardiac Biomarker POCT Diagnostic Device Industry Sales Model and Sales Channels
10.7.1 Cardiac Biomarker POCT Diagnostic Device Sales Model
10.7.2 Cardiac Biomarker POCT Diagnostic Device Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Cardiac Biomarker POCT Diagnostic Device Introduction
1.2 World Cardiac Biomarker POCT Diagnostic Device Supply & Forecast
1.2.1 World Cardiac Biomarker POCT Diagnostic Device Production Value (2021 & 2025 & 2032)
1.2.2 World Cardiac Biomarker POCT Diagnostic Device Production (2021-2032)
1.2.3 World Cardiac Biomarker POCT Diagnostic Device Pricing Trends (2021-2032)
1.3 World Cardiac Biomarker POCT Diagnostic Device Production by Region (Based on Production Site)
1.3.1 World Cardiac Biomarker POCT Diagnostic Device Production Value by Region (2021-2032)
1.3.2 World Cardiac Biomarker POCT Diagnostic Device Production by Region (2021-2032)
1.3.3 World Cardiac Biomarker POCT Diagnostic Device Average Price by Region (2021-2032)
1.3.4 North America Cardiac Biomarker POCT Diagnostic Device Production (2021-2032)
1.3.5 Europe Cardiac Biomarker POCT Diagnostic Device Production (2021-2032)
1.3.6 China Cardiac Biomarker POCT Diagnostic Device Production (2021-2032)
1.3.7 Japan Cardiac Biomarker POCT Diagnostic Device Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cardiac Biomarker POCT Diagnostic Device Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cardiac Biomarker POCT Diagnostic Device Major Market Trends
2 DEMAND SUMMARY
2.1 World Cardiac Biomarker POCT Diagnostic Device Demand (2021-2032)
2.2 World Cardiac Biomarker POCT Diagnostic Device Consumption by Region
2.2.1 World Cardiac Biomarker POCT Diagnostic Device Consumption by Region (2021-2026)
2.2.2 World Cardiac Biomarker POCT Diagnostic Device Consumption Forecast by Region (2027-2032)
2.3 United States Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
2.4 China Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
2.5 Europe Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
2.6 Japan Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
2.7 South Korea Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
2.8 ASEAN Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
2.9 India Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Cardiac Biomarker POCT Diagnostic Device Production Value by Manufacturer (2021-2026)
3.2 World Cardiac Biomarker POCT Diagnostic Device Production by Manufacturer (2021-2026)
3.3 World Cardiac Biomarker POCT Diagnostic Device Average Price by Manufacturer (2021-2026)
3.4 Cardiac Biomarker POCT Diagnostic Device Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cardiac Biomarker POCT Diagnostic Device Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cardiac Biomarker POCT Diagnostic Device in 2025
3.5.3 Global Concentration Ratios (CR8) for Cardiac Biomarker POCT Diagnostic Device in 2025
3.6 Cardiac Biomarker POCT Diagnostic Device Market: Overall Company Footprint Analysis
3.6.1 Cardiac Biomarker POCT Diagnostic Device Market: Region Footprint
3.6.2 Cardiac Biomarker POCT Diagnostic Device Market: Company Product Type Footprint
3.6.3 Cardiac Biomarker POCT Diagnostic Device Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Value Comparison
4.1.1 United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Comparison
4.2.1 United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Cardiac Biomarker POCT Diagnostic Device Consumption Comparison
4.3.1 United States VS China: Cardiac Biomarker POCT Diagnostic Device Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Cardiac Biomarker POCT Diagnostic Device Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Cardiac Biomarker POCT Diagnostic Device Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Cardiac Biomarker POCT Diagnostic Device Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value (2021-2026)
4.4.3 United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production (2021-2026)
4.5 China Based Cardiac Biomarker POCT Diagnostic Device Manufacturers and Market Share
4.5.1 China Based Cardiac Biomarker POCT Diagnostic Device Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value (2021-2026)
4.5.3 China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production (2021-2026)
4.6 Rest of World Based Cardiac Biomarker POCT Diagnostic Device Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Cardiac Biomarker POCT Diagnostic Device Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cardiac Biomarker POCT Diagnostic Device Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Fluorescence Immunoassay
5.2.2 Chemiluminescence Immunoassay
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Cardiac Biomarker POCT Diagnostic Device Production by Type (2021-2032)
5.3.2 World Cardiac Biomarker POCT Diagnostic Device Production Value by Type (2021-2032)
5.3.3 World Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY FORM
6.1 World Cardiac Biomarker POCT Diagnostic Device Market Size Overview by Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Form
6.2.1 Handheld
6.2.2 Benchtop
6.2.3 Other
6.3 Market Segment by Form
6.3.1 World Cardiac Biomarker POCT Diagnostic Device Production by Form (2021-2032)
6.3.2 World Cardiac Biomarker POCT Diagnostic Device Production Value by Form (2021-2032)
6.3.3 World Cardiac Biomarker POCT Diagnostic Device Average Price by Form (2021-2032)
7 MARKET ANALYSIS BY CARDIAC BIOMARKER
7.1 World Cardiac Biomarker POCT Diagnostic Device Market Size Overview by Cardiac Biomarker: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Cardiac Biomarker
7.2.1 Troponin-focused
7.2.2 Natriuretic Peptide-focused
7.2.3 Other
7.3 Market Segment by Cardiac Biomarker
7.3.1 World Cardiac Biomarker POCT Diagnostic Device Production by Cardiac Biomarker (2021-2032)
7.3.2 World Cardiac Biomarker POCT Diagnostic Device Production Value by Cardiac Biomarker (2021-2032)
7.3.3 World Cardiac Biomarker POCT Diagnostic Device Average Price by Cardiac Biomarker (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cardiac Biomarker POCT Diagnostic Device Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Cardiac Biomarker POCT Diagnostic Device Production by Application (2021-2032)
8.3.2 World Cardiac Biomarker POCT Diagnostic Device Production Value by Application (2021-2032)
8.3.3 World Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Roche
9.1.1 Roche Details
9.1.2 Roche Major Business
9.1.3 Roche Cardiac Biomarker POCT Diagnostic Device Product and Services
9.1.4 Roche Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Roche Recent Developments/Updates
9.1.6 Roche Competitive Strengths & Weaknesses
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Details
9.2.2 Abbott Laboratories Major Business
9.2.3 Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Product and Services
9.2.4 Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Abbott Laboratories Recent Developments/Updates
9.2.6 Abbott Laboratories Competitive Strengths & Weaknesses
9.3 QuidelOrtho Corporation
9.3.1 QuidelOrtho Corporation Details
9.3.2 QuidelOrtho Corporation Major Business
9.3.3 QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Product and Services
9.3.4 QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 QuidelOrtho Corporation Recent Developments/Updates
9.3.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
9.4 Radiometer Medical
9.4.1 Radiometer Medical Details
9.4.2 Radiometer Medical Major Business
9.4.3 Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Product and Services
9.4.4 Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Radiometer Medical Recent Developments/Updates
9.4.6 Radiometer Medical Competitive Strengths & Weaknesses
9.5 Siemens Healthineers
9.5.1 Siemens Healthineers Details
9.5.2 Siemens Healthineers Major Business
9.5.3 Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Product and Services
9.5.4 Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Siemens Healthineers Recent Developments/Updates
9.5.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.6 PHC Holdings
9.6.1 PHC Holdings Details
9.6.2 PHC Holdings Major Business
9.6.3 PHC Holdings Cardiac Biomarker POCT Diagnostic Device Product and Services
9.6.4 PHC Holdings Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 PHC Holdings Recent Developments/Updates
9.6.6 PHC Holdings Competitive Strengths & Weaknesses
9.7 Guangzhou Wondfo Biotech
9.7.1 Guangzhou Wondfo Biotech Details
9.7.2 Guangzhou Wondfo Biotech Major Business
9.7.3 Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
9.7.4 Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Guangzhou Wondfo Biotech Recent Developments/Updates
9.7.6 Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
9.8 Getein Biotech
9.8.1 Getein Biotech Details
9.8.2 Getein Biotech Major Business
9.8.3 Getein Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
9.8.4 Getein Biotech Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Getein Biotech Recent Developments/Updates
9.8.6 Getein Biotech Competitive Strengths & Weaknesses
9.9 Boditech Med
9.9.1 Boditech Med Details
9.9.2 Boditech Med Major Business
9.9.3 Boditech Med Cardiac Biomarker POCT Diagnostic Device Product and Services
9.9.4 Boditech Med Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Boditech Med Recent Developments/Updates
9.9.6 Boditech Med Competitive Strengths & Weaknesses
9.10 SD BIOSENSOR
9.10.1 SD BIOSENSOR Details
9.10.2 SD BIOSENSOR Major Business
9.10.3 SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Product and Services
9.10.4 SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 SD BIOSENSOR Recent Developments/Updates
9.10.6 SD BIOSENSOR Competitive Strengths & Weaknesses
9.11 Lepu Medical Technology
9.11.1 Lepu Medical Technology Details
9.11.2 Lepu Medical Technology Major Business
9.11.3 Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Product and Services
9.11.4 Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Lepu Medical Technology Recent Developments/Updates
9.11.6 Lepu Medical Technology Competitive Strengths & Weaknesses
9.12 Humasis
9.12.1 Humasis Details
9.12.2 Humasis Major Business
9.12.3 Humasis Cardiac Biomarker POCT Diagnostic Device Product and Services
9.12.4 Humasis Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Humasis Recent Developments/Updates
9.12.6 Humasis Competitive Strengths & Weaknesses
9.13 NanoEntek
9.13.1 NanoEntek Details
9.13.2 NanoEntek Major Business
9.13.3 NanoEntek Cardiac Biomarker POCT Diagnostic Device Product and Services
9.13.4 NanoEntek Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 NanoEntek Recent Developments/Updates
9.13.6 NanoEntek Competitive Strengths & Weaknesses
9.14 Xiamen Biotime Biotechnology
9.14.1 Xiamen Biotime Biotechnology Details
9.14.2 Xiamen Biotime Biotechnology Major Business
9.14.3 Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
9.14.4 Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Xiamen Biotime Biotechnology Recent Developments/Updates
9.14.6 Xiamen Biotime Biotechnology Competitive Strengths & Weaknesses
9.15 Nanjing Lansion Biotechnology
9.15.1 Nanjing Lansion Biotechnology Details
9.15.2 Nanjing Lansion Biotechnology Major Business
9.15.3 Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
9.15.4 Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Nanjing Lansion Biotechnology Recent Developments/Updates
9.15.6 Nanjing Lansion Biotechnology Competitive Strengths & Weaknesses
9.16 Shenzhen Micropoint Biotechnologies
9.16.1 Shenzhen Micropoint Biotechnologies Details
9.16.2 Shenzhen Micropoint Biotechnologies Major Business
9.16.3 Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Product and Services
9.16.4 Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Shenzhen Micropoint Biotechnologies Recent Developments/Updates
9.16.6 Shenzhen Micropoint Biotechnologies Competitive Strengths & Weaknesses
9.17 Shijiazhuang Hipro Biotechnology
9.17.1 Shijiazhuang Hipro Biotechnology Details
9.17.2 Shijiazhuang Hipro Biotechnology Major Business
9.17.3 Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
9.17.4 Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Shijiazhuang Hipro Biotechnology Recent Developments/Updates
9.17.6 Shijiazhuang Hipro Biotechnology Competitive Strengths & Weaknesses
9.18 AEHEALTH
9.18.1 AEHEALTH Details
9.18.2 AEHEALTH Major Business
9.18.3 AEHEALTH Cardiac Biomarker POCT Diagnostic Device Product and Services
9.18.4 AEHEALTH Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 AEHEALTH Recent Developments/Updates
9.18.6 AEHEALTH Competitive Strengths & Weaknesses
9.19 Guangzhou KOFA Biotechnology
9.19.1 Guangzhou KOFA Biotechnology Details
9.19.2 Guangzhou KOFA Biotechnology Major Business
9.19.3 Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
9.19.4 Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Guangzhou KOFA Biotechnology Recent Developments/Updates
9.19.6 Guangzhou KOFA Biotechnology Competitive Strengths & Weaknesses
9.20 Response Biomedical
9.20.1 Response Biomedical Details
9.20.2 Response Biomedical Major Business
9.20.3 Response Biomedical Cardiac Biomarker POCT Diagnostic Device Product and Services
9.20.4 Response Biomedical Cardiac Biomarker POCT Diagnostic Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Response Biomedical Recent Developments/Updates
9.20.6 Response Biomedical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cardiac Biomarker POCT Diagnostic Device Industry Chain
10.2 Cardiac Biomarker POCT Diagnostic Device Upstream Analysis
10.2.1 Cardiac Biomarker POCT Diagnostic Device Core Raw Materials
10.2.2 Main Manufacturers of Cardiac Biomarker POCT Diagnostic Device Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Cardiac Biomarker POCT Diagnostic Device Production Mode
10.6 Cardiac Biomarker POCT Diagnostic Device Procurement Model
10.7 Cardiac Biomarker POCT Diagnostic Device Industry Sales Model and Sales Channels
10.7.1 Cardiac Biomarker POCT Diagnostic Device Sales Model
10.7.2 Cardiac Biomarker POCT Diagnostic Device Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Cardiac Biomarker POCT Diagnostic Device Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Cardiac Biomarker POCT Diagnostic Device Production Value by Region (2021-2026) & (USD Million)
Table 3. World Cardiac Biomarker POCT Diagnostic Device Production Value by Region (2027-2032) & (USD Million)
Table 4. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Region (2021-2026)
Table 5. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Region (2027-2032)
Table 6. World Cardiac Biomarker POCT Diagnostic Device Production by Region (2021-2026) & (Units)
Table 7. World Cardiac Biomarker POCT Diagnostic Device Production by Region (2027-2032) & (Units)
Table 8. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Region (2021-2026)
Table 9. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Region (2027-2032)
Table 10. World Cardiac Biomarker POCT Diagnostic Device Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Cardiac Biomarker POCT Diagnostic Device Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Cardiac Biomarker POCT Diagnostic Device Major Market Trends
Table 13. World Cardiac Biomarker POCT Diagnostic Device Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Cardiac Biomarker POCT Diagnostic Device Consumption by Region (2021-2026) & (Units)
Table 15. World Cardiac Biomarker POCT Diagnostic Device Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Cardiac Biomarker POCT Diagnostic Device Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Cardiac Biomarker POCT Diagnostic Device Producers in 2025
Table 18. World Cardiac Biomarker POCT Diagnostic Device Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Cardiac Biomarker POCT Diagnostic Device Producers in 2025
Table 20. World Cardiac Biomarker POCT Diagnostic Device Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Cardiac Biomarker POCT Diagnostic Device Company Evaluation Quadrant
Table 22. World Cardiac Biomarker POCT Diagnostic Device Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Cardiac Biomarker POCT Diagnostic Device Production Site of Key Manufacturer
Table 24. Cardiac Biomarker POCT Diagnostic Device Market: Company Product Type Footprint
Table 25. Cardiac Biomarker POCT Diagnostic Device Market: Company Product Application Footprint
Table 26. Cardiac Biomarker POCT Diagnostic Device Competitive Factors
Table 27. Cardiac Biomarker POCT Diagnostic Device New Entrant and Capacity Expansion Plans
Table 28. Cardiac Biomarker POCT Diagnostic Device Mergers & Acquisitions Activity
Table 29. United States VS China Cardiac Biomarker POCT Diagnostic Device Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Cardiac Biomarker POCT Diagnostic Device Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Cardiac Biomarker POCT Diagnostic Device Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Cardiac Biomarker POCT Diagnostic Device Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Market Share (2021-2026)
Table 37. China Based Cardiac Biomarker POCT Diagnostic Device Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Market Share (2021-2026)
Table 42. Rest of World Based Cardiac Biomarker POCT Diagnostic Device Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Market Share (2021-2026)
Table 47. World Cardiac Biomarker POCT Diagnostic Device Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Cardiac Biomarker POCT Diagnostic Device Production by Type (2021-2026) & (Units)
Table 49. World Cardiac Biomarker POCT Diagnostic Device Production by Type (2027-2032) & (Units)
Table 50. World Cardiac Biomarker POCT Diagnostic Device Production Value by Type (2021-2026) & (USD Million)
Table 51. World Cardiac Biomarker POCT Diagnostic Device Production Value by Type (2027-2032) & (USD Million)
Table 52. World Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Cardiac Biomarker POCT Diagnostic Device Production Value by Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Cardiac Biomarker POCT Diagnostic Device Production by Form (2021-2026) & (Units)
Table 56. World Cardiac Biomarker POCT Diagnostic Device Production by Form (2027-2032) & (Units)
Table 57. World Cardiac Biomarker POCT Diagnostic Device Production Value by Form (2021-2026) & (USD Million)
Table 58. World Cardiac Biomarker POCT Diagnostic Device Production Value by Form (2027-2032) & (USD Million)
Table 59. World Cardiac Biomarker POCT Diagnostic Device Average Price by Form (2021-2026) & (US$/Unit)
Table 60. World Cardiac Biomarker POCT Diagnostic Device Average Price by Form (2027-2032) & (US$/Unit)
Table 61. World Cardiac Biomarker POCT Diagnostic Device Production Value by Cardiac Biomarker, (USD Million), 2021 & 2025 & 2032
Table 62. World Cardiac Biomarker POCT Diagnostic Device Production by Cardiac Biomarker (2021-2026) & (Units)
Table 63. World Cardiac Biomarker POCT Diagnostic Device Production by Cardiac Biomarker (2027-2032) & (Units)
Table 64. World Cardiac Biomarker POCT Diagnostic Device Production Value by Cardiac Biomarker (2021-2026) & (USD Million)
Table 65. World Cardiac Biomarker POCT Diagnostic Device Production Value by Cardiac Biomarker (2027-2032) & (USD Million)
Table 66. World Cardiac Biomarker POCT Diagnostic Device Average Price by Cardiac Biomarker (2021-2026) & (US$/Unit)
Table 67. World Cardiac Biomarker POCT Diagnostic Device Average Price by Cardiac Biomarker (2027-2032) & (US$/Unit)
Table 68. World Cardiac Biomarker POCT Diagnostic Device Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Cardiac Biomarker POCT Diagnostic Device Production by Application (2021-2026) & (Units)
Table 70. World Cardiac Biomarker POCT Diagnostic Device Production by Application (2027-2032) & (Units)
Table 71. World Cardiac Biomarker POCT Diagnostic Device Production Value by Application (2021-2026) & (USD Million)
Table 72. World Cardiac Biomarker POCT Diagnostic Device Production Value by Application (2027-2032) & (USD Million)
Table 73. World Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Roche Basic Information, Manufacturing Base and Competitors
Table 76. Roche Major Business
Table 77. Roche Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 78. Roche Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Roche Recent Developments/Updates
Table 80. Roche Competitive Strengths & Weaknesses
Table 81. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 82. Abbott Laboratories Major Business
Table 83. Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 84. Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Abbott Laboratories Recent Developments/Updates
Table 86. Abbott Laboratories Competitive Strengths & Weaknesses
Table 87. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 88. QuidelOrtho Corporation Major Business
Table 89. QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 90. QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. QuidelOrtho Corporation Recent Developments/Updates
Table 92. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 93. Radiometer Medical Basic Information, Manufacturing Base and Competitors
Table 94. Radiometer Medical Major Business
Table 95. Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 96. Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Radiometer Medical Recent Developments/Updates
Table 98. Radiometer Medical Competitive Strengths & Weaknesses
Table 99. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 100. Siemens Healthineers Major Business
Table 101. Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 102. Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Siemens Healthineers Recent Developments/Updates
Table 104. Siemens Healthineers Competitive Strengths & Weaknesses
Table 105. PHC Holdings Basic Information, Manufacturing Base and Competitors
Table 106. PHC Holdings Major Business
Table 107. PHC Holdings Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 108. PHC Holdings Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. PHC Holdings Recent Developments/Updates
Table 110. PHC Holdings Competitive Strengths & Weaknesses
Table 111. Guangzhou Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 112. Guangzhou Wondfo Biotech Major Business
Table 113. Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 114. Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Guangzhou Wondfo Biotech Recent Developments/Updates
Table 116. Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
Table 117. Getein Biotech Basic Information, Manufacturing Base and Competitors
Table 118. Getein Biotech Major Business
Table 119. Getein Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 120. Getein Biotech Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Getein Biotech Recent Developments/Updates
Table 122. Getein Biotech Competitive Strengths & Weaknesses
Table 123. Boditech Med Basic Information, Manufacturing Base and Competitors
Table 124. Boditech Med Major Business
Table 125. Boditech Med Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 126. Boditech Med Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Boditech Med Recent Developments/Updates
Table 128. Boditech Med Competitive Strengths & Weaknesses
Table 129. SD BIOSENSOR Basic Information, Manufacturing Base and Competitors
Table 130. SD BIOSENSOR Major Business
Table 131. SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 132. SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. SD BIOSENSOR Recent Developments/Updates
Table 134. SD BIOSENSOR Competitive Strengths & Weaknesses
Table 135. Lepu Medical Technology Basic Information, Manufacturing Base and Competitors
Table 136. Lepu Medical Technology Major Business
Table 137. Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 138. Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Lepu Medical Technology Recent Developments/Updates
Table 140. Lepu Medical Technology Competitive Strengths & Weaknesses
Table 141. Humasis Basic Information, Manufacturing Base and Competitors
Table 142. Humasis Major Business
Table 143. Humasis Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 144. Humasis Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Humasis Recent Developments/Updates
Table 146. Humasis Competitive Strengths & Weaknesses
Table 147. NanoEntek Basic Information, Manufacturing Base and Competitors
Table 148. NanoEntek Major Business
Table 149. NanoEntek Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 150. NanoEntek Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. NanoEntek Recent Developments/Updates
Table 152. NanoEntek Competitive Strengths & Weaknesses
Table 153. Xiamen Biotime Biotechnology Basic Information, Manufacturing Base and Competitors
Table 154. Xiamen Biotime Biotechnology Major Business
Table 155. Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 156. Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Xiamen Biotime Biotechnology Recent Developments/Updates
Table 158. Xiamen Biotime Biotechnology Competitive Strengths & Weaknesses
Table 159. Nanjing Lansion Biotechnology Basic Information, Manufacturing Base and Competitors
Table 160. Nanjing Lansion Biotechnology Major Business
Table 161. Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 162. Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Nanjing Lansion Biotechnology Recent Developments/Updates
Table 164. Nanjing Lansion Biotechnology Competitive Strengths & Weaknesses
Table 165. Shenzhen Micropoint Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 166. Shenzhen Micropoint Biotechnologies Major Business
Table 167. Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 168. Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Shenzhen Micropoint Biotechnologies Recent Developments/Updates
Table 170. Shenzhen Micropoint Biotechnologies Competitive Strengths & Weaknesses
Table 171. Shijiazhuang Hipro Biotechnology Basic Information, Manufacturing Base and Competitors
Table 172. Shijiazhuang Hipro Biotechnology Major Business
Table 173. Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 174. Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Shijiazhuang Hipro Biotechnology Recent Developments/Updates
Table 176. Shijiazhuang Hipro Biotechnology Competitive Strengths & Weaknesses
Table 177. AEHEALTH Basic Information, Manufacturing Base and Competitors
Table 178. AEHEALTH Major Business
Table 179. AEHEALTH Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 180. AEHEALTH Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. AEHEALTH Recent Developments/Updates
Table 182. AEHEALTH Competitive Strengths & Weaknesses
Table 183. Guangzhou KOFA Biotechnology Basic Information, Manufacturing Base and Competitors
Table 184. Guangzhou KOFA Biotechnology Major Business
Table 185. Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 186. Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Guangzhou KOFA Biotechnology Recent Developments/Updates
Table 188. Guangzhou KOFA Biotechnology Competitive Strengths & Weaknesses
Table 189. Response Biomedical Basic Information, Manufacturing Base and Competitors
Table 190. Response Biomedical Major Business
Table 191. Response Biomedical Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 192. Response Biomedical Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Response Biomedical Recent Developments/Updates
Table 194. Response Biomedical Competitive Strengths & Weaknesses
Table 195. Global Key Players of Cardiac Biomarker POCT Diagnostic Device Upstream (Raw Materials)
Table 196. Global Cardiac Biomarker POCT Diagnostic Device Typical Customers
Table 197. Cardiac Biomarker POCT Diagnostic Device Typical Distributors
Table 1. World Cardiac Biomarker POCT Diagnostic Device Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Cardiac Biomarker POCT Diagnostic Device Production Value by Region (2021-2026) & (USD Million)
Table 3. World Cardiac Biomarker POCT Diagnostic Device Production Value by Region (2027-2032) & (USD Million)
Table 4. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Region (2021-2026)
Table 5. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Region (2027-2032)
Table 6. World Cardiac Biomarker POCT Diagnostic Device Production by Region (2021-2026) & (Units)
Table 7. World Cardiac Biomarker POCT Diagnostic Device Production by Region (2027-2032) & (Units)
Table 8. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Region (2021-2026)
Table 9. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Region (2027-2032)
Table 10. World Cardiac Biomarker POCT Diagnostic Device Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Cardiac Biomarker POCT Diagnostic Device Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Cardiac Biomarker POCT Diagnostic Device Major Market Trends
Table 13. World Cardiac Biomarker POCT Diagnostic Device Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Cardiac Biomarker POCT Diagnostic Device Consumption by Region (2021-2026) & (Units)
Table 15. World Cardiac Biomarker POCT Diagnostic Device Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Cardiac Biomarker POCT Diagnostic Device Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Cardiac Biomarker POCT Diagnostic Device Producers in 2025
Table 18. World Cardiac Biomarker POCT Diagnostic Device Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Cardiac Biomarker POCT Diagnostic Device Producers in 2025
Table 20. World Cardiac Biomarker POCT Diagnostic Device Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Cardiac Biomarker POCT Diagnostic Device Company Evaluation Quadrant
Table 22. World Cardiac Biomarker POCT Diagnostic Device Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Cardiac Biomarker POCT Diagnostic Device Production Site of Key Manufacturer
Table 24. Cardiac Biomarker POCT Diagnostic Device Market: Company Product Type Footprint
Table 25. Cardiac Biomarker POCT Diagnostic Device Market: Company Product Application Footprint
Table 26. Cardiac Biomarker POCT Diagnostic Device Competitive Factors
Table 27. Cardiac Biomarker POCT Diagnostic Device New Entrant and Capacity Expansion Plans
Table 28. Cardiac Biomarker POCT Diagnostic Device Mergers & Acquisitions Activity
Table 29. United States VS China Cardiac Biomarker POCT Diagnostic Device Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Cardiac Biomarker POCT Diagnostic Device Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Cardiac Biomarker POCT Diagnostic Device Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Cardiac Biomarker POCT Diagnostic Device Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Market Share (2021-2026)
Table 37. China Based Cardiac Biomarker POCT Diagnostic Device Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Market Share (2021-2026)
Table 42. Rest of World Based Cardiac Biomarker POCT Diagnostic Device Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Market Share (2021-2026)
Table 47. World Cardiac Biomarker POCT Diagnostic Device Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Cardiac Biomarker POCT Diagnostic Device Production by Type (2021-2026) & (Units)
Table 49. World Cardiac Biomarker POCT Diagnostic Device Production by Type (2027-2032) & (Units)
Table 50. World Cardiac Biomarker POCT Diagnostic Device Production Value by Type (2021-2026) & (USD Million)
Table 51. World Cardiac Biomarker POCT Diagnostic Device Production Value by Type (2027-2032) & (USD Million)
Table 52. World Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Cardiac Biomarker POCT Diagnostic Device Production Value by Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Cardiac Biomarker POCT Diagnostic Device Production by Form (2021-2026) & (Units)
Table 56. World Cardiac Biomarker POCT Diagnostic Device Production by Form (2027-2032) & (Units)
Table 57. World Cardiac Biomarker POCT Diagnostic Device Production Value by Form (2021-2026) & (USD Million)
Table 58. World Cardiac Biomarker POCT Diagnostic Device Production Value by Form (2027-2032) & (USD Million)
Table 59. World Cardiac Biomarker POCT Diagnostic Device Average Price by Form (2021-2026) & (US$/Unit)
Table 60. World Cardiac Biomarker POCT Diagnostic Device Average Price by Form (2027-2032) & (US$/Unit)
Table 61. World Cardiac Biomarker POCT Diagnostic Device Production Value by Cardiac Biomarker, (USD Million), 2021 & 2025 & 2032
Table 62. World Cardiac Biomarker POCT Diagnostic Device Production by Cardiac Biomarker (2021-2026) & (Units)
Table 63. World Cardiac Biomarker POCT Diagnostic Device Production by Cardiac Biomarker (2027-2032) & (Units)
Table 64. World Cardiac Biomarker POCT Diagnostic Device Production Value by Cardiac Biomarker (2021-2026) & (USD Million)
Table 65. World Cardiac Biomarker POCT Diagnostic Device Production Value by Cardiac Biomarker (2027-2032) & (USD Million)
Table 66. World Cardiac Biomarker POCT Diagnostic Device Average Price by Cardiac Biomarker (2021-2026) & (US$/Unit)
Table 67. World Cardiac Biomarker POCT Diagnostic Device Average Price by Cardiac Biomarker (2027-2032) & (US$/Unit)
Table 68. World Cardiac Biomarker POCT Diagnostic Device Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Cardiac Biomarker POCT Diagnostic Device Production by Application (2021-2026) & (Units)
Table 70. World Cardiac Biomarker POCT Diagnostic Device Production by Application (2027-2032) & (Units)
Table 71. World Cardiac Biomarker POCT Diagnostic Device Production Value by Application (2021-2026) & (USD Million)
Table 72. World Cardiac Biomarker POCT Diagnostic Device Production Value by Application (2027-2032) & (USD Million)
Table 73. World Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Roche Basic Information, Manufacturing Base and Competitors
Table 76. Roche Major Business
Table 77. Roche Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 78. Roche Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Roche Recent Developments/Updates
Table 80. Roche Competitive Strengths & Weaknesses
Table 81. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 82. Abbott Laboratories Major Business
Table 83. Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 84. Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Abbott Laboratories Recent Developments/Updates
Table 86. Abbott Laboratories Competitive Strengths & Weaknesses
Table 87. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 88. QuidelOrtho Corporation Major Business
Table 89. QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 90. QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. QuidelOrtho Corporation Recent Developments/Updates
Table 92. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 93. Radiometer Medical Basic Information, Manufacturing Base and Competitors
Table 94. Radiometer Medical Major Business
Table 95. Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 96. Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Radiometer Medical Recent Developments/Updates
Table 98. Radiometer Medical Competitive Strengths & Weaknesses
Table 99. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 100. Siemens Healthineers Major Business
Table 101. Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 102. Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Siemens Healthineers Recent Developments/Updates
Table 104. Siemens Healthineers Competitive Strengths & Weaknesses
Table 105. PHC Holdings Basic Information, Manufacturing Base and Competitors
Table 106. PHC Holdings Major Business
Table 107. PHC Holdings Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 108. PHC Holdings Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. PHC Holdings Recent Developments/Updates
Table 110. PHC Holdings Competitive Strengths & Weaknesses
Table 111. Guangzhou Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 112. Guangzhou Wondfo Biotech Major Business
Table 113. Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 114. Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Guangzhou Wondfo Biotech Recent Developments/Updates
Table 116. Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
Table 117. Getein Biotech Basic Information, Manufacturing Base and Competitors
Table 118. Getein Biotech Major Business
Table 119. Getein Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 120. Getein Biotech Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Getein Biotech Recent Developments/Updates
Table 122. Getein Biotech Competitive Strengths & Weaknesses
Table 123. Boditech Med Basic Information, Manufacturing Base and Competitors
Table 124. Boditech Med Major Business
Table 125. Boditech Med Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 126. Boditech Med Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Boditech Med Recent Developments/Updates
Table 128. Boditech Med Competitive Strengths & Weaknesses
Table 129. SD BIOSENSOR Basic Information, Manufacturing Base and Competitors
Table 130. SD BIOSENSOR Major Business
Table 131. SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 132. SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. SD BIOSENSOR Recent Developments/Updates
Table 134. SD BIOSENSOR Competitive Strengths & Weaknesses
Table 135. Lepu Medical Technology Basic Information, Manufacturing Base and Competitors
Table 136. Lepu Medical Technology Major Business
Table 137. Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 138. Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Lepu Medical Technology Recent Developments/Updates
Table 140. Lepu Medical Technology Competitive Strengths & Weaknesses
Table 141. Humasis Basic Information, Manufacturing Base and Competitors
Table 142. Humasis Major Business
Table 143. Humasis Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 144. Humasis Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Humasis Recent Developments/Updates
Table 146. Humasis Competitive Strengths & Weaknesses
Table 147. NanoEntek Basic Information, Manufacturing Base and Competitors
Table 148. NanoEntek Major Business
Table 149. NanoEntek Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 150. NanoEntek Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. NanoEntek Recent Developments/Updates
Table 152. NanoEntek Competitive Strengths & Weaknesses
Table 153. Xiamen Biotime Biotechnology Basic Information, Manufacturing Base and Competitors
Table 154. Xiamen Biotime Biotechnology Major Business
Table 155. Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 156. Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Xiamen Biotime Biotechnology Recent Developments/Updates
Table 158. Xiamen Biotime Biotechnology Competitive Strengths & Weaknesses
Table 159. Nanjing Lansion Biotechnology Basic Information, Manufacturing Base and Competitors
Table 160. Nanjing Lansion Biotechnology Major Business
Table 161. Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 162. Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Nanjing Lansion Biotechnology Recent Developments/Updates
Table 164. Nanjing Lansion Biotechnology Competitive Strengths & Weaknesses
Table 165. Shenzhen Micropoint Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 166. Shenzhen Micropoint Biotechnologies Major Business
Table 167. Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 168. Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Shenzhen Micropoint Biotechnologies Recent Developments/Updates
Table 170. Shenzhen Micropoint Biotechnologies Competitive Strengths & Weaknesses
Table 171. Shijiazhuang Hipro Biotechnology Basic Information, Manufacturing Base and Competitors
Table 172. Shijiazhuang Hipro Biotechnology Major Business
Table 173. Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 174. Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Shijiazhuang Hipro Biotechnology Recent Developments/Updates
Table 176. Shijiazhuang Hipro Biotechnology Competitive Strengths & Weaknesses
Table 177. AEHEALTH Basic Information, Manufacturing Base and Competitors
Table 178. AEHEALTH Major Business
Table 179. AEHEALTH Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 180. AEHEALTH Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. AEHEALTH Recent Developments/Updates
Table 182. AEHEALTH Competitive Strengths & Weaknesses
Table 183. Guangzhou KOFA Biotechnology Basic Information, Manufacturing Base and Competitors
Table 184. Guangzhou KOFA Biotechnology Major Business
Table 185. Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 186. Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Guangzhou KOFA Biotechnology Recent Developments/Updates
Table 188. Guangzhou KOFA Biotechnology Competitive Strengths & Weaknesses
Table 189. Response Biomedical Basic Information, Manufacturing Base and Competitors
Table 190. Response Biomedical Major Business
Table 191. Response Biomedical Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 192. Response Biomedical Cardiac Biomarker POCT Diagnostic Device Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Response Biomedical Recent Developments/Updates
Table 194. Response Biomedical Competitive Strengths & Weaknesses
Table 195. Global Key Players of Cardiac Biomarker POCT Diagnostic Device Upstream (Raw Materials)
Table 196. Global Cardiac Biomarker POCT Diagnostic Device Typical Customers
Table 197. Cardiac Biomarker POCT Diagnostic Device Typical Distributors
LIST OF FIGURES
Figure 1. Cardiac Biomarker POCT Diagnostic Device Picture
Figure 2. World Cardiac Biomarker POCT Diagnostic Device Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Cardiac Biomarker POCT Diagnostic Device Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Cardiac Biomarker POCT Diagnostic Device Production (2021-2032) & (Units)
Figure 5. World Cardiac Biomarker POCT Diagnostic Device Average Price (2021-2032) & (US$/Unit)
Figure 6. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Region (2021-2032)
Figure 7. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Region (2021-2032)
Figure 8. North America Cardiac Biomarker POCT Diagnostic Device Production (2021-2032) & (Units)
Figure 9. Europe Cardiac Biomarker POCT Diagnostic Device Production (2021-2032) & (Units)
Figure 10. China Cardiac Biomarker POCT Diagnostic Device Production (2021-2032) & (Units)
Figure 11. Japan Cardiac Biomarker POCT Diagnostic Device Production (2021-2032) & (Units)
Figure 12. Cardiac Biomarker POCT Diagnostic Device Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 15. World Cardiac Biomarker POCT Diagnostic Device Consumption Market Share by Region (2021-2032)
Figure 16. United States Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 17. China Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 18. Europe Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 19. Japan Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 20. South Korea Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 21. ASEAN Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 22. India Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 23. Producer Shipments of Cardiac Biomarker POCT Diagnostic Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cardiac Biomarker POCT Diagnostic Device Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cardiac Biomarker POCT Diagnostic Device Markets in 2025
Figure 26. United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Cardiac Biomarker POCT Diagnostic Device Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Market Share 2025
Figure 30. China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Market Share 2025
Figure 32. World Cardiac Biomarker POCT Diagnostic Device Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Type in 2025
Figure 34. Fluorescence Immunoassay
Figure 35. Chemiluminescence Immunoassay
Figure 36. Other
Figure 37. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Type (2021-2032)
Figure 38. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Type (2021-2032)
Figure 39. World Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Cardiac Biomarker POCT Diagnostic Device Production Value by Form, (USD Million), 2021 & 2025 & 2032
Figure 41. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Form in 2025
Figure 42. Handheld
Figure 43. Benchtop
Figure 44. Other
Figure 45. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Form (2021-2032)
Figure 46. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Form (2021-2032)
Figure 47. World Cardiac Biomarker POCT Diagnostic Device Average Price by Form (2021-2032) & (US$/Unit)
Figure 48. World Cardiac Biomarker POCT Diagnostic Device Production Value by Cardiac Biomarker, (USD Million), 2021 & 2025 & 2032
Figure 49. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Cardiac Biomarker in 2025
Figure 50. Troponin-focused
Figure 51. Natriuretic Peptide-focused
Figure 52. Other
Figure 53. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Cardiac Biomarker (2021-2032)
Figure 54. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Cardiac Biomarker (2021-2032)
Figure 55. World Cardiac Biomarker POCT Diagnostic Device Average Price by Cardiac Biomarker (2021-2032) & (US$/Unit)
Figure 56. World Cardiac Biomarker POCT Diagnostic Device Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Application in 2025
Figure 58. Hospital
Figure 59. Clinic
Figure 60. Others
Figure 61. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Application (2021-2032)
Figure 62. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Application (2021-2032)
Figure 63. World Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Cardiac Biomarker POCT Diagnostic Device Industry Chain
Figure 65. Cardiac Biomarker POCT Diagnostic Device Procurement Model
Figure 66. Cardiac Biomarker POCT Diagnostic Device Sales Model
Figure 67. Cardiac Biomarker POCT Diagnostic Device Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Cardiac Biomarker POCT Diagnostic Device Picture
Figure 2. World Cardiac Biomarker POCT Diagnostic Device Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Cardiac Biomarker POCT Diagnostic Device Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Cardiac Biomarker POCT Diagnostic Device Production (2021-2032) & (Units)
Figure 5. World Cardiac Biomarker POCT Diagnostic Device Average Price (2021-2032) & (US$/Unit)
Figure 6. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Region (2021-2032)
Figure 7. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Region (2021-2032)
Figure 8. North America Cardiac Biomarker POCT Diagnostic Device Production (2021-2032) & (Units)
Figure 9. Europe Cardiac Biomarker POCT Diagnostic Device Production (2021-2032) & (Units)
Figure 10. China Cardiac Biomarker POCT Diagnostic Device Production (2021-2032) & (Units)
Figure 11. Japan Cardiac Biomarker POCT Diagnostic Device Production (2021-2032) & (Units)
Figure 12. Cardiac Biomarker POCT Diagnostic Device Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 15. World Cardiac Biomarker POCT Diagnostic Device Consumption Market Share by Region (2021-2032)
Figure 16. United States Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 17. China Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 18. Europe Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 19. Japan Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 20. South Korea Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 21. ASEAN Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 22. India Cardiac Biomarker POCT Diagnostic Device Consumption (2021-2032) & (Units)
Figure 23. Producer Shipments of Cardiac Biomarker POCT Diagnostic Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cardiac Biomarker POCT Diagnostic Device Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cardiac Biomarker POCT Diagnostic Device Markets in 2025
Figure 26. United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Cardiac Biomarker POCT Diagnostic Device Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Cardiac Biomarker POCT Diagnostic Device Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Market Share 2025
Figure 30. China Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Cardiac Biomarker POCT Diagnostic Device Production Market Share 2025
Figure 32. World Cardiac Biomarker POCT Diagnostic Device Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Type in 2025
Figure 34. Fluorescence Immunoassay
Figure 35. Chemiluminescence Immunoassay
Figure 36. Other
Figure 37. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Type (2021-2032)
Figure 38. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Type (2021-2032)
Figure 39. World Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Cardiac Biomarker POCT Diagnostic Device Production Value by Form, (USD Million), 2021 & 2025 & 2032
Figure 41. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Form in 2025
Figure 42. Handheld
Figure 43. Benchtop
Figure 44. Other
Figure 45. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Form (2021-2032)
Figure 46. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Form (2021-2032)
Figure 47. World Cardiac Biomarker POCT Diagnostic Device Average Price by Form (2021-2032) & (US$/Unit)
Figure 48. World Cardiac Biomarker POCT Diagnostic Device Production Value by Cardiac Biomarker, (USD Million), 2021 & 2025 & 2032
Figure 49. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Cardiac Biomarker in 2025
Figure 50. Troponin-focused
Figure 51. Natriuretic Peptide-focused
Figure 52. Other
Figure 53. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Cardiac Biomarker (2021-2032)
Figure 54. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Cardiac Biomarker (2021-2032)
Figure 55. World Cardiac Biomarker POCT Diagnostic Device Average Price by Cardiac Biomarker (2021-2032) & (US$/Unit)
Figure 56. World Cardiac Biomarker POCT Diagnostic Device Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Application in 2025
Figure 58. Hospital
Figure 59. Clinic
Figure 60. Others
Figure 61. World Cardiac Biomarker POCT Diagnostic Device Production Market Share by Application (2021-2032)
Figure 62. World Cardiac Biomarker POCT Diagnostic Device Production Value Market Share by Application (2021-2032)
Figure 63. World Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Cardiac Biomarker POCT Diagnostic Device Industry Chain
Figure 65. Cardiac Biomarker POCT Diagnostic Device Procurement Model
Figure 66. Cardiac Biomarker POCT Diagnostic Device Sales Model
Figure 67. Cardiac Biomarker POCT Diagnostic Device Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
